A systematic review and meta analysis published in the journal Obesity in 2025 found that lean mass made up about 30.8 percent of total body weight lost during GLP 1 therapy
Safety and effects of anti-obesity medications on weight loss, cardiometabolic, and psychological outcomes in people living with overweight or obesity: a systematic review and meta-analysis
Is compounded oral semaglutide from PlexusDx the same quality as brand-name Rybelsus
As we look ahead, we urge our preclinical colleagues to dig deeper into how GLP-1s influence tumor biology, not only through metabolic pathways, but through their emerging effects on the immune system, she said
The Wegovy injectables may be considered less of a commitment, having to only administer them once weekly, instead of every day
But some people may benefit from continued or maintenance use, and long-term safety is still being evaluated in ongoing studies